(Q36554987)

14 August 2017

1 reference

title

Phosphodiesterase-5 inhibitors and their hemodynamic effects (English)

1 reference

14 August 2017

L Michael Prisant

1

1 reference

14 August 2017

publication date

1 August 2006

1 reference

Current Hypertension Reports

14 August 2017

published in

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

345-351

1 reference

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

14 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-006-0075-Y

Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-006-0075-Y

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction

21 January 2018

1 reference

12 December 2020

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study

1 reference

12 December 2020

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association

1 reference

12 December 2020

Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.

1 reference

12 December 2020

Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial

1 reference

12 December 2020

Erectile dysfunction and subsequent cardiovascular disease

1 reference

12 December 2020

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

12 December 2020

Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction

1 reference

12 December 2020

Effect of sildenafil on arterial stiffness and wave reflection

1 reference

12 December 2020

Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives

1 reference

12 December 2020

Effects of sildenafil citrate (viagra) on blood pressure in normotensive and hypertensive men.

1 reference

12 December 2020

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

1 reference

12 December 2020

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

1 reference

12 December 2020

Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.

1 reference

12 December 2020

Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

The human sexuality education of physicians in North American medical schools

1 reference

12 December 2020

Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group

1 reference

12 December 2020

Time course of the interaction between tadalafil and nitrates

1 reference

12 December 2020

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

12 December 2020

Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia

1 reference

12 December 2020

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

1 reference

12 December 2020

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions

1 reference

12 December 2020

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

1 reference

12 December 2020

Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide

1 reference

12 December 2020

Sexual dysfunction with antihypertensive drugs

1 reference

12 December 2020

Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy

1 reference

12 December 2020

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies

1 reference

12 December 2020

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.

1 reference

12 December 2020

Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group

1 reference

12 December 2020

Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina

1 reference

12 December 2020

10.1007/S11906-006-0075-Y

Identifiers

DOI

1 reference

14 August 2017

1 reference